A clinical investigation plan is the protocol document that defines the rationale, objectives, design, methodology, monitoring, and statistical considerations for a medical device clinical investigation. It appears in clinical evaluation and regulatory submissions for medical devices and must be approved by ethics committees and, where applicable, competent authorities before the investigation begins.
In translation and localization, the CIP appears in medical device clinical investigation applications, ethics submissions, and investigator site documentation. Translators may adapt the plan for multiple study sites, patient consent materials, or monitoring plans, and must align terms with the device description and risk documentation.
A common error is translating “clinical investigation plan” as a generic study schedule or business plan, losing its regulatory role as the controlling protocol. Merging CIP terminology with drug trial protocol terms can also create confusion about device endpoints, investigational device status, or safety reporting.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →